The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Today, Jennifer R. Brown, MD, PhD, will be honored with the Michael J. Keating Outstanding Achievement Award, which recognizes a clinician’s significant research contributions
One of SOHO’s most dedicated and longest-standing members, Dr. Lonial chairs the Education Committee, serves as Treasurer, and is editor in chief of
The July/August issue features an editorial by Jerry Radich, MD, a feature article on radiotherapy in blood cancers, and an Interview with Alice
Artificial intelligence (AI) has seen a staggering influx of investment across nearly every sector, and hematologic oncology is no exception. While some may
Dr. Trněný, a professor of medical oncology at Charles University Hospital in Prague, discusses results from the phase 3 INMIND study.
New findings published in The Lancet Haematology suggest that ASTX727, a fixed-dose, fully oral combination of decitabine and cedazuridine, could be a potential
New findings published in the journal Haematologica suggest that the genesis of chronic lymphocytic leukemia (CLL) involves competition among multiple B-cell clones with
Listen to Susan O’Brien, MD, professor of medicine, and Catherine C. Coombs, MD, associate professor of medicine, both of the Chao Family Comprehensive
Lawrence N. Shulman, MD, a medical oncologist at the University of Pennsylvania’s Abramson Cancer Center, discussed US cancer surveillance challenges in a recent
A next-generation blood test is able to diagnosis and monitor multiple myeloma (MM) and its precursor conditions by utilizing single-cell sequencing to profile
